Vancomycin Susceptibility of Oxacillin-Resistant Staphylococcus aureus Isolates Causing Nosocomial Bloodstream Infections-Reference-Cited by-同舟云学术

Vancomycin Susceptibility of Oxacillin-Resistant Staphylococcus aureus Isolates Causing Nosocomial Bloodstream Infections

Published:2002-06 Issue:6 Volume:40 Page:2249-2250
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Tallent Sandra M.¹,Bischoff Tammy¹,Climo Michael¹²,Ostrowsky Belinda¹,Wenzel Richard P.¹,Edmond Michael B.¹

Affiliation:

1. Department of Internal Medicine, Medical College of Virginia Campus of Virginia Commonwealth University

2. Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia

Abstract

ABSTRACT Nosocomial oxacillin-resistant Staphylococcus aureus (ORSA) bloodstream isolates were tested to determine the prevalence of vancomycin heteroresistance. We screened 619 ORSA nosocomial bloodstream isolates from 36 hospitals between 1997 and 2000. Only one isolate exhibiting heterotypic resistance was detected. Thus, vancomycin heteroresistance in clinical bloodstream isolates remains rare in the United States.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.40.6.2249-2250.2002

Reference15 articles.

1. Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H. G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J. Clin. Microbiol. Infect. Dis.18:691-696.

2. A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical Staphylococcus aureus Isolates

3. Centers for Disease Control and Prevention. 2000. National Nosocomial Infection Surveillance (NNIS) System report, data summary from January 1992-April 2000, issued June 2000. Am. J. Infect. Control28:429-448.

4. Chesneau, O., A. Morvan, and N. El Solh. 2000. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J. Antimicrob. Chemother.45:887-890.

5. Edmond, M. B., S. Wallace, D. McClish, M. Pfaller, R. Jones, and R. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis.29:239-244.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis;Scientific Reports;2020-07-29

2. Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria;African Health Sciences;2017-09-18

3. Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates;PLOS ONE;2015-08-19

4. Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-IntermediateStaphylococcus aureusIsolates;Antimicrobial Agents and Chemotherapy;2010-11-15

5. Novel pharmaceutical molecules against emerging resistant gram-positive cocci;Brazilian Journal of Infectious Diseases;2010-02